Diagnostics (PSA)
"The Value of Prostate Specific Antigen in Early Diagnosis of Prostate Cancer: The Study of Men Born in 1913."
Published in Cancer Weekly, October 23rd, 1995
According to the authors' abstract of an article published in Journal of Urology, "Purpose: We attempt to elucidate the performance of serum prostate specific antigen (PSA) as a screening test for prostate cancer. Materials and Methods: We analyzed sera stored since 1980 in a nested case-control study. Results: The 36 patients with prostate cancer had a markedly greater mean serum PSA level than did 68 subjects without cancer (22.71 versus 2.67, respectively, P<0.0001). Among the controls 24% had a serum PSA of greater than 4.0 (mu)g/L. A serum PSA value exceeding 4.0 (mu)g/L. in 1980 was associated with a 20-fold excess risk of cancer between 1981...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1995-10-23)
More Articles from Cancer Weekly
- Combination Therapies
Gene Therapy Boosts the Killing Effect of Antitumor Radiation Therapy - Gene Delivery
High Voltage Gold Exchange Efficiently Transfers Mutant cDNA - Ovarian Cancer
Adjunctive Immunotherapy Shows Promise - Animal Models
Murine Model Makes Applicable Advances for Human Gene Therapy - Blood Banking (HTLV I/II)
Better Detection Method and Confirmation Assay Are Needed - Breast Cancer (Diagnostics)
Test Linked To Increase in Detection of Lymph Node Spread - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
